Brexit and the impact on patient access to medicines and medical technologies
The UK’s plans to leave the European Union (EU) and the EU’s single market could have serious implications for patients’ access to medicines and medical technologies.
This briefing explores how UK and EU citizens could be affected by the disruption in trade that could result from the UK’s exit from the EU, as well as in the event of lack of cooperation in the regulation of medicines and devices between the EU and the UK post Brexit.
Last modified: 20 September 2023
Last reviewed: 20 September 2023